Prediabetes is like the two minute warning just before the end of the first half in a football game...
Category: Products & Tech
Medtronic has announced that the results of the in-clinic ASPIRE (Automation to Simulate Pancreatic Insulin REsponse) study met its efficacy endpoints and showed a 19% reduction in time spent below the low glucose threshold in patients using the MiniMed Paradigm System featuring Low Glucose Suspend automation, compared...
How many things do you forget every day? Where did I put my keys? Did I lock the door? Did I turn off the lights before I left the house? And... ever wonder whether or not you took your insulin injection?
Life Scan has announced the voluntary recall of their OneTouch Verio IQ Meter. The reason given by LifeScan for the recall of the glucose meter is that under very specific circumstances the OneTouch Verio IQ Meter produces an error that causes the meter to turn itself off when a user attempts to access...
"Paula Deen is not the diabetes poster child," said Ambre Morely, associate director of product communications at Novo Nordisk. "She's an everyday person with type 2 diabetes...
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in the European Union (EU) for the expanded use of Byetta (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos® (pioglitazone)...
Insulet Corporation, the company behind OmniPod Insulin Management System, announced it has signed a worldwide agreement with LifeScan, Inc. to integrate LifeScan's OneTouch blood glucose monitoring technology into...
Finnish diabetes technology company Mendor has announced an international partnership distribution agreement with a leading pharmaceutical company in the diabetes field, Merck Serono, covering the United Kingdom diabetes market.
Mendor’s first product, a blood glucose meter...
Mendor, a Finnish company committed to the design, development and marketing of advanced diabetes management products, has developed an all- in-one glucose meter.
The newly approved type 2 diabetes drug Bydureon, made by Amylin Pharmaceuticals and Alkermes plc, is now available by prescription in U.S. pharmacies.
Bydureon is the first and only once-weekly treatment for type 2 diabetes. It was approved by the US FDA ...